Prevalence of COVID-19-associated pulmonary aspergillosis: critical review and conclusions

M Egger, L Bussini, M Hoenigl, M Bartoletti - Journal of Fungi, 2022 - mdpi.com
… with the accuracy of reported prevalence. Current guidelines recommend treatment of CAPA
prevalence and the role of CAPA as an important opportunistic infection affecting COVID-19 …

[HTML][HTML] Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis

RM Kariyawasam, TC Dingle, BE Kula… - Clinical Microbiology …, 2022 - Elsevier
Pulmonary aspergillosis may complicate coronavirus disease 2019 (COVID-19) and
contribute to excess … Summary forest plots for prevalence of COVID-19–associated pulmonary

[HTML][HTML] Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

A Alanio, S Dellière, S Fodil, S Bretagne… - The Lancet …, 2020 - ncbi.nlm.nih.gov
… of developing secondary infections including invasive pulmonary aspergillosis (IPA). …
aspergillosis in immunocompromised patients. Therefore, an algorithm to discriminate Aspergillus

Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia

G Segrelles‐Calvo, GRS Araújo, E Llopis‐Pastor… - Mycoses, 2021 - Wiley Online Library
… reported seven patients with COVID-19-associated pulmonary aspergillosis (CAPA) … of
aspergillosis in all of these patients. Larger cohort studies are needed to unravel the role of COVID

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

A Fekkar, D Neofytos… - Clinical …, 2021 - clinicalmicrobiologyandinfection …
Prevalence of putative invasive pulmonary aspergillosis in … pulmonary aspergillosis among
critically ill covid-19 patients. … pulmonary aspergillosis among critically ill covid-19 patients. …

[HTML][HTML] COVID-19 associated with pulmonary aspergillosis: A literature review

CC Lai, WL Yu - Journal of Microbiology, Immunology and Infection, 2021 - Elsevier
… in COVID-19 patients, we should pay more attention to Aspergillus because invasive pulmonary
aspergillosis (IPA) … vulnerable to IPA, which prevalence can reach up to 15% of patients. …

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients

F Lamoth, E Glampedakis… - Clinical …, 2020 - clinicalmicrobiologyandinfection …
… -associated pulmonary aspergillosis in ICU … COVID-19 has been previously reported among
smaller cohorts of patients under mechanical ventilation (N = 13 to 31) with a prevalence of …

Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review

WH Chong, KP Neu - Journal of Hospital Infection, 2021 - Elsevier
COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive pulmonary
aspergillosis occurring in COVID-19 patients. The purpose of this review was to discuss the …

Diagnosing COVID-19-associated pulmonary aspergillosis

PE Verweij, JP Gangneux, M Bassetti… - The Lancet …, 2020 - thelancet.com
… invasive pulmonary aspergillosis in patients with COVID-… COVID-19 and invasive pulmonary
aspergillosis were recently described in France (33% of 27 admitted to the ICU with COVID

[HTML][HTML] COVID-19–associated pulmonary aspergillosis, March–August 2020

J Salmanton-García, R Sprute, J Stemler… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
… had coronavirus disease–associated pulmonary aspergillosis (… CAPA was diagnosed a
median of 10 days after coronavirus … Men had a higher (2.6:1) prevalence of CAPA than women. …